Table S2.
Univariate and multivariate analyses of prognostic factors for HCC recurrence in Chinese patients with HBV-related HCC
| Factor | Univariate analysis
|
Multivariate analysis
|
|||||
|---|---|---|---|---|---|---|---|
| Patients, n (%) | HR | 95% confidence interval | P-value | HR | 95% confidence interval | P-value | |
| Positive for HBeAg | |||||||
| Yes | 40 (15.5) | 6.06 | 2.961–12.419 | <0.001 | 5.36 | 1.523–18.863 | 0.009 |
| No | 218 (84.5) | ||||||
| Portal vein thrombus, n (%) | |||||||
| Yes | 61 (23.6) | 2.00 | 1.105–3.616 | 0.022 | 1.70 | 0.227–3.135 | 0.047 |
| No | 197 (76.4) | ||||||
| Blood transfusion, n (%) | |||||||
| Yes | 51 (19.8) | 64.05 | 23.319–175.904 | <0.001 | 218.15 | 21.946–2,168.391 | <0.001 |
| No | 207 (80.2) | ||||||
Abbreviations: HBeAg, hepatitis B e antigen; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HR, hazard ratio.